ES2326115T3 - Derivados de la quinoleina, procedimiento de sintesis, y medicamentos que contienen estos derivados. - Google Patents

Derivados de la quinoleina, procedimiento de sintesis, y medicamentos que contienen estos derivados. Download PDF

Info

Publication number
ES2326115T3
ES2326115T3 ES02795314T ES02795314T ES2326115T3 ES 2326115 T3 ES2326115 T3 ES 2326115T3 ES 02795314 T ES02795314 T ES 02795314T ES 02795314 T ES02795314 T ES 02795314T ES 2326115 T3 ES2326115 T3 ES 2326115T3
Authority
ES
Spain
Prior art keywords
formula
derivatives
defined above
acid
sub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02795314T
Other languages
English (en)
Spanish (es)
Inventor
Jean D'angelo
Marie Bayle
Christophe Benard
Didier Desma Le
Michele Danet
Laurence Janson
Marc Le Bret
Herve Leh
Jean-Francois Mouscadet
Frederic Subra
Fatima Zouhiri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Institut Gustave Roussy
Institut National de la Santé et de la Recherche Médicale
Bioalliance Pharma SA
Université Paris-Sud
Original Assignee
Centre National de la Recherche Scientifique
Institut Gustave Roussy
Institut National de la Santé et de la Recherche Médicale
Bioalliance Pharma SA
Université Paris-Sud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique, Institut Gustave Roussy, Institut National de la Santé et de la Recherche Médicale, Bioalliance Pharma SA, Université Paris-Sud filed Critical Centre National de la Recherche Scientifique
Application granted granted Critical
Publication of ES2326115T3 publication Critical patent/ES2326115T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES02795314T 2001-10-12 2002-10-14 Derivados de la quinoleina, procedimiento de sintesis, y medicamentos que contienen estos derivados. Expired - Lifetime ES2326115T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113209 2001-10-12
FR0113209A FR2830863B1 (fr) 2001-10-12 2001-10-12 Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives

Publications (1)

Publication Number Publication Date
ES2326115T3 true ES2326115T3 (es) 2009-10-01

Family

ID=8868255

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02795314T Expired - Lifetime ES2326115T3 (es) 2001-10-12 2002-10-14 Derivados de la quinoleina, procedimiento de sintesis, y medicamentos que contienen estos derivados.

Country Status (10)

Country Link
US (2) US7064133B2 (enExample)
EP (1) EP1461319B1 (enExample)
JP (1) JP2005508350A (enExample)
AT (1) ATE430134T1 (enExample)
DE (1) DE60232186D1 (enExample)
DK (1) DK1461319T3 (enExample)
ES (1) ES2326115T3 (enExample)
FR (1) FR2830863B1 (enExample)
IL (2) IL161320A0 (enExample)
WO (1) WO2003031413A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2830863B1 (fr) * 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives
FR2839646B1 (fr) * 2002-05-17 2008-04-11 Bioalliance Pharma Utilisation de derives de quinoleine a effet anti-integrase et ses applications
US7132432B2 (en) * 2003-06-05 2006-11-07 Bristol-Myers Squibb Company Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
TW200510425A (en) 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
ATE433974T1 (de) 2003-09-19 2009-07-15 Gilead Sciences Inc Azachinolinolphosphonatverbindungen als integraseinhibitoren
JP2008542352A (ja) * 2005-06-01 2008-11-27 ビオアリアンス ファルマ キノリン化合物及び他のｈｉｖ感染治療薬を含む相乗作用のコンビネーション

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761687B1 (fr) * 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
FR2830863B1 (fr) * 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives

Also Published As

Publication number Publication date
US20060148849A1 (en) 2006-07-06
FR2830863B1 (fr) 2004-01-30
EP1461319B1 (fr) 2009-04-29
WO2003031413A1 (fr) 2003-04-17
FR2830863A1 (fr) 2003-04-18
JP2005508350A (ja) 2005-03-31
DK1461319T3 (da) 2009-08-03
US7064133B2 (en) 2006-06-20
ATE430134T1 (de) 2009-05-15
US20040259911A1 (en) 2004-12-23
IL161320A0 (en) 2004-09-27
IL161320A (en) 2009-09-01
DE60232186D1 (de) 2009-06-10
EP1461319A1 (fr) 2004-09-29

Similar Documents

Publication Publication Date Title
ES2332434T3 (es) Derivados de quirolina como inhibidores de la integrasa del vih.
Aggarwal et al. Synthesis and biological evaluation of prodrugs of zidovudine
Patil et al. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group
Tandon et al. Synthesis and biological evaluation of novel 1, 4-naphthoquinone derivatives as antibacterial and antiviral agents
US20150218120A1 (en) Hiv integrase inhibitors
CA3082191A1 (en) N4-hydroxycytidine and derivatives and anti-viral uses related thereto
US6541483B2 (en) Acridone-derived compounds useful as antineoplastic and antiretroviral agents
NO973363D0 (no) Neuraminsyrederivater, deres fremstilling og medisinske bruk
Sergheraert et al. Synthesis and anti-HIV evaluation of D4T and D4T 5'-monophosphate prodrugs
WO2003053989A1 (en) Masked phosphate containing nucleoside derivatives and their use as antivirals
Li et al. Hybrid molecules based on an emodin scaffold. Synthesis and activity against SARS-CoV-2 and Plasmodium
JPH11507375A (ja) 低分子によるｒｎａ／リガンド結合の阻害
EP2045246A1 (en) Derivatives of benzo[d] isothiazoles as histone deacetylase inhibitors
US7064133B2 (en) Quinoline derivatives process of synthesis and medicaments containing these derivatives
US20060094755A1 (en) Novel quinoline-based metal chelators as antiviral agents
CA2163174C (en) Hindered aromatic ester compounds useful as anti-viral agents
TW200813066A (en) Novel compounds
Al-Abed et al. Inhibition of HIV-1 nuclear import via Schiff base formation with arylene bis (methylketone) compounds
Maurin et al. Design, synthesis, and anti-integrase activity of catechol–DKA hybrids
US10266550B2 (en) Bacterial topoisomerase I inhibitors with antibacterial activity
US9108943B2 (en) Photoreactive benzamide probes for histone deacetylase 2
RU2359954C2 (ru) Производные бензотрополона, обладающие анти-вич активностью, фармацевтическая композиция, способ ингибирования вич-1 интегразы
US20060063938A1 (en) Compounds to treat hiv infection and aids
CN119080839B (zh) 一种抗病毒药物及其用途
AU2006323278B2 (en) Dioxolane derivates for the treatment of cancer